CN112274755B - Immersive virtual VR biofeedback therapeutic instrument for tinnitus - Google Patents
Immersive virtual VR biofeedback therapeutic instrument for tinnitus Download PDFInfo
- Publication number
- CN112274755B CN112274755B CN202011082388.6A CN202011082388A CN112274755B CN 112274755 B CN112274755 B CN 112274755B CN 202011082388 A CN202011082388 A CN 202011082388A CN 112274755 B CN112274755 B CN 112274755B
- Authority
- CN
- China
- Prior art keywords
- tinnitus
- multimedia
- biological sign
- user
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M21/00—Other devices or methods to cause a change in the state of consciousness; Devices for producing or ending sleep by mechanical, optical, or acoustical means, e.g. for hypnosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F11/00—Methods or devices for treatment of the ears or hearing sense; Non-electric hearing aids; Methods or devices for enabling ear patients to achieve auditory perception through physiological senses other than hearing sense; Protective devices for the ears, carried on the body or in the hand
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M21/00—Other devices or methods to cause a change in the state of consciousness; Devices for producing or ending sleep by mechanical, optical, or acoustical means, e.g. for hypnosis
- A61M2021/0005—Other devices or methods to cause a change in the state of consciousness; Devices for producing or ending sleep by mechanical, optical, or acoustical means, e.g. for hypnosis by the use of a particular sense, or stimulus
- A61M2021/0027—Other devices or methods to cause a change in the state of consciousness; Devices for producing or ending sleep by mechanical, optical, or acoustical means, e.g. for hypnosis by the use of a particular sense, or stimulus by the hearing sense
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M21/00—Other devices or methods to cause a change in the state of consciousness; Devices for producing or ending sleep by mechanical, optical, or acoustical means, e.g. for hypnosis
- A61M2021/0005—Other devices or methods to cause a change in the state of consciousness; Devices for producing or ending sleep by mechanical, optical, or acoustical means, e.g. for hypnosis by the use of a particular sense, or stimulus
- A61M2021/0044—Other devices or methods to cause a change in the state of consciousness; Devices for producing or ending sleep by mechanical, optical, or acoustical means, e.g. for hypnosis by the use of a particular sense, or stimulus by the sight sense
- A61M2021/005—Other devices or methods to cause a change in the state of consciousness; Devices for producing or ending sleep by mechanical, optical, or acoustical means, e.g. for hypnosis by the use of a particular sense, or stimulus by the sight sense images, e.g. video
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2230/00—Measuring parameters of the user
- A61M2230/04—Heartbeat characteristics, e.g. ECG, blood pressure modulation
- A61M2230/06—Heartbeat rate only
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2230/00—Measuring parameters of the user
- A61M2230/08—Other bio-electrical signals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2230/00—Measuring parameters of the user
- A61M2230/08—Other bio-electrical signals
- A61M2230/10—Electroencephalographic signals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2230/00—Measuring parameters of the user
- A61M2230/40—Respiratory characteristics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2230/00—Measuring parameters of the user
- A61M2230/50—Temperature
Abstract
The invention discloses an immersive tinnitus virtual VR biofeedback therapeutic instrument which comprises a VR host, a VR helmet and a biological sign monitoring system, wherein the VR host comprises a central controller and a multimedia storage and playing module, the multimedia storage and playing module stores a plurality of real or virtual simulation video and audio scenery scenes, the scenery scenes are displayed to tinnitus users through the VR helmet, the biological sign monitoring system is used for collecting biological sign data of the tinnitus users, and the central controller is respectively connected with the multimedia storage and playing module and the biological sign monitoring system. This therapeutic instrument can show virtual scene in the front of the eyes of user, makes the user freely relax in VR, realizes vision experience and sound experience dual stimulation, reaches the effect that the tinnitus was improved in the treatment.
Description
Technical Field
The invention relates to an otology treatment instrument, in particular to an immersive tinnitus virtual VR biofeedback treatment instrument.
Background
Tinnitus is a common symptom, and is caused by many systemic and otic disorders. Idiopathic tinnitus refers to a sensation of sound in the absence of exogenous sound or electrical stimulation. According to epidemiological data statistics, about 35% of adults have tinnitus experience, about 3-7% of adults seek medical attention due to tinnitus, and 0.5-2.5% of adults complain of tinnitus and seriously affect life, so that people are difficult to pay attention, normally communicate, work and sleep, and even have suicide tendency. Meanwhile, people at different ages can have tinnitus, the incidence rate of the tinnitus gradually increases along with the increase of the ages, and the latest research shows that the tinnitus gradually tends to be in a low-age trend, and the reported incidence rate is similar to that of adults.
Due to the complex etiology and unclear mechanism of tinnitus, no unified and effective method for treating tinnitus is clinically available at present. According to the latest us tinnitus clinical application guidelines in 2014, it is stated that based on evidence-based medical evidence statistics, antidepressants, anticonvulsants, anxiolytics, intratympanic administration, and neurotropic ginkgo biloba extracts or other dietary supplements are not recommended as conventional methods for treating tinnitus, nor are transcranial magnetic stimulation recommended for treating tinnitus. The guideline expert group only advises patients to receive tinnitus sound treatment after hearing tests to understand tinnitus side, duration and hearing, tinnitus condition.
Disclosure of Invention
The invention aims to provide an immersive tinnitus virtual VR biofeedback therapeutic apparatus, which displays a virtual scene in front of eyes of a user, so that the user can relax freely in VR, double stimulation of visual experience and sound experience is realized, and the effect of treating and improving tinnitus is achieved.
The above purpose of the invention is realized by the following technical scheme: immersive virtual VR biofeedback therapeutic instrument of tinnitus, its characterized in that: the therapeutic apparatus comprises a VR host, a VR helmet and a biological sign monitoring system, wherein the VR host comprises a central controller and a multimedia storage and playing module, the multimedia storage and playing module stores a plurality of real or virtual simulation video and audio scenery scenes, the scenery scenes are displayed to a tinnitus user through the VR helmet, the biological sign monitoring system is used for collecting biological sign data of the tinnitus user, and the central controller is respectively connected with the multimedia storage and playing module and the biological sign monitoring system; the multimedia storing and playing module randomly plays the stored multimedia scenery scene as the currently played multimedia in the first stage of the treatment of the therapeutic apparatus, if the biological sign data values of the tinnitus users collected by the biological sign monitoring system are not in the normal biological sign data value range preset in the central controller within the playing time length S1 range of the currently played multimedia, after the playing time length S1 of the currently played multimedia is finished, the central controller sends an instruction to the multimedia storage and playing module, the multimedia which is relatively milder and more stable than the currently played multimedia is switched to, the switched relatively milder and more stable multimedia is used as the multimedia which is continuously played to enter a second stage of treatment, and meanwhile, the user is prompted to do relaxation training for adjusting breath by voice; if the biological sign data value of the tinnitus user collected by the biological sign monitoring system is partially or completely within the normal biological sign data value range preset in the central controller within the playing time range of the currently played multimedia, the currently played multimedia is not switched, and after the playing time of the currently played multimedia is over S1, the currently played multimedia is used as the continuously played multimedia to enter the second stage of subsequent treatment; the continuously played multimedia is continuously played in the second stage of treatment of the therapeutic apparatus, and within the playing time length S2 of the continuously played multimedia in the second stage of treatment, once the central controller receives that the biological sign data value of the user acquired by the biological sign monitoring system is within the optimal biological sign data value range preset in the central controller, the central controller sends an instruction to the multimedia storage and playing module, and adds an additional graph corresponding to the biological sign of the user on a scenery scene picture of the continuously played multimedia in real time, and meanwhile, the biological sign monitoring system stores the acquired biological sign data value of the user.
According to the therapeutic apparatus, the immersive VR host and the VR helmet are two mutually independent components, the VR host plays real or virtual simulated video and audio scenery scenes and is matched with voice guidance and relaxing music, real-time feedback and interaction of scenes and sound are performed according to collected biological sign data of a user, the VR helmet performs image optimization sound optimization decoding according to the data of the VR host, the video and audio scenery scenes are displayed in front of eyes of the user, the user can relax freely in VR, double stimulation of visual experience and sound experience is realized, and tinnitus treatment and improvement effects are achieved.
According to the therapeutic apparatus, a tinnitus user can relax freely in VR in the first treatment stage, double stimulation of visual experience and sound experience is realized, and the effect of treating and improving tinnitus is achieved; further stimulating the tinnitus user in the second stage of treatment, thereby alleviating or eliminating the trouble of tinnitus of the user and achieving the purpose of treatment.
In the invention, the biological sign monitoring system collects seven parameters of electrocardio, electroencephalogram, myoelectricity, skin electricity, pulse, respiration and body temperature of the tinnitus user, wherein in the first stage of treatment, the collected biological sign data of the tinnitus user only refers to the pulse of the tinnitus user, and in the second stage of treatment, the collected biological sign data of the tinnitus user comprises all seven parameters of electrocardio, electroencephalogram, myoelectricity, skin electricity, pulse, respiration and body temperature.
In the invention, in the first stage of treatment, the normal pulse data value preset in the central controller is in the range of 60-80 times/minute.
In the invention, in the first stage of treatment of the therapeutic apparatus, the playing time length S1 of the currently played multimedia is 15-30 minutes, and the switching frequency of the currently played multimedia is at most 1 time; in the second stage of the therapeutic apparatus, the playing time length S2 of the multimedia which is continuously played is 15-30 minutes.
In the second stage of treatment, the optimal data value ranges of electrocardio, electroencephalogram, myoelectricity, skin electricity, pulse, respiration and body temperature preset in the central controller are respectively electrocardio: 60-80 times/min; electroencephalogram: 12-15 Hz; myoelectricity: less than 5 uv; skin power: less than 5 mho; pulse: 60-80 times/min; breathing: 16-20 times per minute; body temperature: 33.8 to 35 ℃; when the monitored electrocardio, electroencephalogram, myoelectricity, electrodermal electricity, pulse, respiration and body temperature are in the optimal range, additional figures such as hawks, stags, horses, elks, small foxes, safflowers and yellow flowers are correspondingly generated respectively.
The therapeutic apparatus provided by the invention plays personalized music to perform personalized music relieving on tinnitus users, and also integrates a system through a special real or virtual simulation scene and voice relaxation guidance, so that the use process is simple and easy to operate.
Drawings
The invention is described in further detail below with reference to the drawings and the detailed description.
Fig. 1 is a schematic block diagram of the immersive tinnitus virtual VR biofeedback treatment instrument of the present invention.
Detailed Description
The immersive virtual VR biofeedback therapeutic instrument for tinnitus, as shown in fig. 1, comprises a VR host, a VR helmet and a biological sign monitoring system, wherein the VR host comprises a central controller, a multimedia storage and playing module, the multimedia storage and playing module stores a plurality of real or virtual simulation video and audio scenery scenes, the scenery scenes are displayed to a tinnitus user through the VR helmet, the biological sign monitoring system is used for collecting biological sign data of the tinnitus user, the collected biological signs of the tinnitus user comprise seven parameters including electrocardio, electroencephalogram, myoelectricity, electrodermal, pulse, respiration and body temperature, and the central controller is respectively connected with the multimedia storage and playing module and the biological sign monitoring system.
The multimedia storage and playing module randomly plays the stored multimedia landscape scenes as the currently played multimedia in the first stage of treatment of the therapeutic apparatus, the playing time length S1 of the currently played multimedia is 20 minutes, and the playing time length S1 can also be a value within a range of 15-30 minutes. In the first stage of treatment, the collected biological sign data of the tinnitus user only refers to the pulse of the tinnitus user, and the normal pulse data value preset in the central controller ranges from 60 to 80 times/minute. If the biological sign data values of the tinnitus user collected by the biological sign monitoring system are not in the normal biological sign data value range preset in the central controller within the playing time length S1 range of the currently played multimedia, the central controller sends an instruction to the multimedia storage and playing module after the playing time length S1 of the currently played multimedia is finished, the multimedia which is relatively mild and stable compared with the currently played multimedia is switched to, the relatively mild and stable multimedia is relatively mild in sound, the pictures are relatively mild, the switched relatively mild and stable multimedia is used as the continuously played multimedia to enter the second stage of treatment, and meanwhile, the voice prompts the user to do relaxation training for adjusting breathing; if the biological sign data value of the tinnitus user, which is acquired by the biological sign monitoring system and received by the central controller, is partially or completely within the normal biological sign data value range which is preset in the central controller within the playing time range of the currently played multimedia, the currently played multimedia is not switched, namely the switching frequency of the currently played multimedia is at most 1 time; after the playing time length S1 of the currently played multimedia is over, the currently played multimedia is used as the multimedia which is continuously played to enter the second stage of subsequent treatment, so that the tinnitus user can relax freely in VR, double stimulation of visual experience and sound experience is realized, and the effect of treating and improving tinnitus is achieved.
The continuously played multimedia is continuously played in the second stage of the treatment of the therapeutic apparatus, the playing time length S2 of the continuously played multimedia is 20 minutes, and the playing time length S2 can also be taken within the range of 15-30 minutes. In the second stage of treatment, the acquired biological sign data of the tinnitus user comprise seven parameters including electrocardio, electroencephalogram, myoelectricity, electrodermal electricity, pulse, respiration and body temperature, and the optimal data value ranges of the electrocardio, the electroencephalogram, the myoelectricity, the electrodermal electricity, the pulse, the respiration and the body temperature, which are preset in the central controller, are respectively as follows:
electrocardio: 60-80 times/min; electroencephalogram: 12-15 Hz; myoelectricity: less than 5 uv; skin power: less than 5 mho; pulse: 60-80 times/min; breathing: 16-20 times per minute; body temperature: 33.8 to 35 ℃;
when the monitored electrocardio, electroencephalogram, myoelectricity, electrodermal electricity, pulse, respiration and body temperature are in the optimal range, additional figures such as hawks, stags, horses, elks, small foxes, safflowers and yellow flowers are correspondingly generated respectively.
For most users, the indexes of the biological sign parameters are as follows:
electrocardio: normal overspeed of 60-80 times/min & lt 60 brady & gt 100
Electroencephalogram: 22-30 Hz tension 15-18 Hz alert attention 12-15Hz calm attention
8-12 Hz attention dispersion 4-7 Hz drowsiness 1-3 Hz deep sleep
Myoelectricity: the relaxed state is less than 5uv light stress and 5-15 uv high stress and more than 15uv
Skin power: less than 5mho relaxation 5-10 mho slight emotional agitation
10-20 mho emotional agitation > 20mho anxiety/hyperalgesia
Pulse: normal overspeed of 60-80 times/min & lt 60 brady & gt 100
Breathing: normal speed is reduced by less than 12 times/min and increased by more than 24 times
Body temperature: 33.8-35 ℃ of very relaxed temperature of 32.22-33.89 DEG C
Stress at 30-32.22 deg.C and stress less than 29.44 deg.C
Within the range of the playing time length S2 of the multimedia continuously played in the second stage of treatment, once the central controller receives that the biological sign data value of the user acquired by the biological sign monitoring system is within the optimal biological sign data value range preset in the central controller, the central controller sends an instruction to the multimedia storage and playing module, additional graphics corresponding to the biological signs of the user are superimposed on the scene picture of the continuously played multimedia in real time, meanwhile, the biological sign monitoring system stores the acquired biological sign data value of the user, and the tinnitus user is further stimulated in the second stage of treatment, so that the trouble of the tinnitus of the user is relieved or eliminated, and the purpose of treatment is achieved.
In the second stage of treatment, when the collected biological sign data value of the user is within the optimal biological sign data value range preset in the central controller, corresponding images of animals or flowers and the like can be superimposed on the continuously played scenery scene picture of multimedia playing in real time.
According to the invention, the eagle corresponding to electrocardio, the stag corresponding to electroencephalogram, the horse corresponding to myoelectricity, the doe corresponding to electrodermal, the small fox corresponding to pulse, the safflower corresponding to respiration and the yellow flower corresponding to body temperature are adopted, when a certain parameter is in the optimal range, a corresponding graph appears, and if the parameter is not in the optimal range, the corresponding graph does not appear, and all parameters are not influenced. For example, if only the data of electroencephalogram, electromyogram, and electrodermal are within the corresponding optimal ranges, only the stags, horses, and stags appear, and the rest of the images do not appear. This gives the user an intuitive visual display and can further stimulate the tinnitus user.
The above embodiments of the present invention are not intended to limit the scope of the present invention, and the embodiments of the present invention are not limited thereto, and various other modifications, substitutions or alterations made to the above structures of the present invention without departing from the basic technical idea of the present invention according to the common technical knowledge and common practice in the art should fall within the scope of the present invention.
Claims (5)
1. Virtual VR biofeedback therapeutic instrument of immersive tinnitus, its characterized in that: the therapeutic apparatus comprises a VR host, a VR helmet and a biological sign monitoring system, wherein the VR host comprises a central controller and a multimedia storage and playing module, the multimedia storage and playing module stores a plurality of real or virtual simulation video and audio scenery scenes, the scenery scenes are displayed to a tinnitus user through the VR helmet, the biological sign monitoring system is used for collecting biological sign data of the tinnitus user, and the central controller is respectively connected with the multimedia storage and playing module and the biological sign monitoring system; the multimedia storing and playing module randomly plays the stored multimedia scenery scene as the currently played multimedia in the first stage of the treatment of the therapeutic apparatus, if the biological sign data values of the tinnitus users collected by the biological sign monitoring system are not in the normal biological sign data value range preset in the central controller within the playing time length S1 range of the currently played multimedia, after the currently played multimedia is finished within the playing time length S1, the central controller sends an instruction to the multimedia storage and playing module, the multimedia which is relatively mild and stable compared with the currently played multimedia is switched, the switched multimedia which is relatively mild and stable is used as the multimedia which is continuously played, the second stage of treatment is carried out, and meanwhile, the user is prompted by voice to carry out relaxation training for adjusting breath; if the biological sign data value of the tinnitus user collected by the biological sign monitoring system is partially or completely within the normal biological sign data value range preset in the central controller within the playing time range of the currently played multimedia, the currently played multimedia is not switched, and after the playing time of the currently played multimedia is over S1, the currently played multimedia is used as the continuously played multimedia to enter the second stage of subsequent treatment; the continuously played multimedia is continuously played in the second stage of treatment of the therapeutic apparatus, and once the central controller receives that the biological sign data value of the user acquired by the biological sign monitoring system is within the optimal biological sign data value range preset in the central controller within the playing time length S2 range of the continuously played multimedia in the second stage of treatment, the central controller sends an instruction to the multimedia storage and playing module, additional graphics corresponding to the biological signs of the user are superimposed on the scene picture of the continuously played multimedia in real time, and meanwhile, the biological sign monitoring system stores the acquired biological sign data value of the user.
2. The immersive tinnitus virtual VR biofeedback treatment instrument of claim 1 wherein: the biological sign monitoring system collects seven parameters of electrocardio, electroencephalogram, myoelectricity, skin electricity, pulse, respiration and body temperature of the tinnitus user, wherein the collected biological sign data of the tinnitus user only indicate the pulse of the tinnitus user in the first stage of treatment, and the collected biological sign data of the tinnitus user comprise seven parameters of electrocardio, electroencephalogram, myoelectricity, skin electricity, pulse, respiration and body temperature in the second stage of treatment.
3. The immersive tinnitus virtual VR biofeedback treatment instrument of claim 2 wherein: in the first stage of treatment, the normal pulse data value preset in the central controller ranges from 60 to 80 times per minute.
4. The immersive tinnitus virtual VR biofeedback treatment instrument of claim 2, wherein: in the first stage of treatment of the therapeutic apparatus, the playing time length S1 of the currently played multimedia is 15-30 minutes, and the switching frequency of the currently played multimedia is at most 1 time; in the second stage of the therapeutic apparatus, the playing time length S2 of the multimedia which is continuously played is 15-30 minutes.
5. The immersive tinnitus virtual VR biofeedback treatment instrument of claim 2, wherein: in the second stage of treatment, the optimal data value ranges of electrocardio, electroencephalogram, myoelectricity, skin electricity, pulse, respiration and body temperature preset in the central controller are respectively electrocardio: 60-80 times/min; electroencephalogram: 12-15 Hz; myoelectricity: less than 5 uv; skin power generation: less than 5 mho; pulse: 60-80 times/min; breathing: 16-20 times per minute; body temperature: 33.8 to 35 ℃; when the monitored electrocardio, electroencephalogram, myoelectricity, electrodermal electricity, pulse, respiration and body temperature are in the optimal range, additional figures such as hawks, stags, horses, elks, small foxes, safflowers and yellow flowers are correspondingly generated respectively.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202011082388.6A CN112274755B (en) | 2020-10-10 | 2020-10-10 | Immersive virtual VR biofeedback therapeutic instrument for tinnitus |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202011082388.6A CN112274755B (en) | 2020-10-10 | 2020-10-10 | Immersive virtual VR biofeedback therapeutic instrument for tinnitus |
Publications (2)
Publication Number | Publication Date |
---|---|
CN112274755A CN112274755A (en) | 2021-01-29 |
CN112274755B true CN112274755B (en) | 2022-09-06 |
Family
ID=74496084
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202011082388.6A Active CN112274755B (en) | 2020-10-10 | 2020-10-10 | Immersive virtual VR biofeedback therapeutic instrument for tinnitus |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN112274755B (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114870197A (en) * | 2022-05-20 | 2022-08-09 | 中国人民解放军空军军医大学 | Immersive psychological massage instrument |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1719432A (en) * | 2005-07-21 | 2006-01-11 | 高春平 | Treating method of system desensitization and its device |
CN202051690U (en) * | 2011-03-31 | 2011-11-30 | 姜鸿彦 | Fitting device for tinnitus treatment |
CN205451066U (en) * | 2016-03-14 | 2016-08-10 | 樊锦鹏 | A children's autistic VR rehabilitation system |
WO2018101590A1 (en) * | 2016-11-30 | 2018-06-07 | 사회복지법인 삼성생명공익재단 | Tinnitus treating system |
CN108428475A (en) * | 2018-05-15 | 2018-08-21 | 段新 | Biofeedback training system based on human body physiological data monitoring and virtual reality |
CN110732072A (en) * | 2019-09-04 | 2020-01-31 | 长春呈实健康实业有限公司 | Instrument for customized sound effect for suppressing tinnitus and sleep disorder |
CN110806803A (en) * | 2019-11-01 | 2020-02-18 | 山东大学 | Integrated interactive system based on virtual reality and multi-source information fusion |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9089707B2 (en) * | 2008-07-02 | 2015-07-28 | The Board Of Regents, The University Of Texas System | Systems, methods and devices for paired plasticity |
-
2020
- 2020-10-10 CN CN202011082388.6A patent/CN112274755B/en active Active
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1719432A (en) * | 2005-07-21 | 2006-01-11 | 高春平 | Treating method of system desensitization and its device |
CN202051690U (en) * | 2011-03-31 | 2011-11-30 | 姜鸿彦 | Fitting device for tinnitus treatment |
CN205451066U (en) * | 2016-03-14 | 2016-08-10 | 樊锦鹏 | A children's autistic VR rehabilitation system |
WO2018101590A1 (en) * | 2016-11-30 | 2018-06-07 | 사회복지법인 삼성생명공익재단 | Tinnitus treating system |
CN108428475A (en) * | 2018-05-15 | 2018-08-21 | 段新 | Biofeedback training system based on human body physiological data monitoring and virtual reality |
CN110732072A (en) * | 2019-09-04 | 2020-01-31 | 长春呈实健康实业有限公司 | Instrument for customized sound effect for suppressing tinnitus and sleep disorder |
CN110806803A (en) * | 2019-11-01 | 2020-02-18 | 山东大学 | Integrated interactive system based on virtual reality and multi-source information fusion |
Also Published As
Publication number | Publication date |
---|---|
CN112274755A (en) | 2021-01-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US9694155B2 (en) | Adjuvant method for the interface of psychosomatic approaches and technology for improving medical outcomes | |
US11051730B2 (en) | Virtual reality biofeedback systems and methods | |
Amores et al. | Promoting relaxation using virtual reality, olfactory interfaces and wearable EEG | |
US10342986B2 (en) | Frequency specific sensory stimulation | |
US5219322A (en) | Psychotherapy apparatus and method for treating undesirable emotional arousal of a patient | |
US11000669B2 (en) | Method of virtual reality system and implementing such method | |
Liu et al. | Neurofeedback games to improve cognitive abilities | |
Schulz et al. | Voice and speech characteristics of persons with Parkinson’s disease pre-and post-pallidotomy surgery: preliminary findings | |
US20180050170A1 (en) | System and method of stress reduction | |
CN112274755B (en) | Immersive virtual VR biofeedback therapeutic instrument for tinnitus | |
Shah et al. | Effectiveness of audiovisual distraction eyeglass method compared to tell-play-do technique among 4–7-year-old children: a randomized controlled trial | |
CN113574608A (en) | Method and system for generating a treatment course | |
JPH11155955A (en) | Phobia treatment equipment | |
Austin et al. | The use of virtual reality hypnosis with two cases of autism spectrum disorder: a feasibility study | |
US20120276506A1 (en) | Method of Treatment | |
CN215231382U (en) | Wake-up prompting system combined with virtual reality technology | |
CN211751684U (en) | Panoramic psychological consulting room | |
Balkany et al. | The ear book: a complete guide to ear disorders and health | |
Perales et al. | A pilot study: VR and binaural sounds for mood management | |
Gu et al. | Research and verification of a new relaxation technology based on virtual reality for human psychological security and psychosomatic recovery | |
Budzynski | The clinical guide to sound and light | |
Wiederhold et al. | Managing pain in military populations with virtual reality | |
Ayan | Laughing matters | |
Shetty et al. | Non-Pharmacological Behaviour Management | |
RU2741216C1 (en) | Method of treating neurotic, psychic disorders, addictive behavior and adaptation to upcoming stresses |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |